Empowered Patient Podcast

Nima Ahmadi, CEO of The Wound Company, highlights the need for qualified and certified wound care experts to work with patients on a continuous basis. This kind of relationship allows the care provider to proactively manage the wound to ensure efficient healing as quickly as possible. Personalized plans are created using AI and data analysis, considering the patient's risk factors and specific details about the wound and their general health condition.

Nima explains, "We think about being in a continuous relationship with everybody who has a wound, ensuring its healing. Then, we continue to be proactive as we manage patients who are at risk of new wounds or repeat wounds so that we're doing everything we can preventatively to prevent that from happening. This is completely different than how we've approached wound care for the last few decades."

"We have certified experts, and our vision is that in ten years, every single American with a wound will have a certified wound care expert from The Wound Company assigned to their care. The expert is quarterbacking their wound care and ensuring they will heal as quickly and cost-effectively as possible. As part of that vision of assigning that coordination, we're also doing virtual and in-person, in some cases, wound care so that it's a one-stop shop experience for the patient to help them heal effectively and efficiently. And we have a tremendous amount of technology and other assets to help our clinicians do that multichannel wound care."

#WoundCare #OstomyCare #Healthcare #Telehealth #NursingShortage

thewound. co

Listen to the podcast here

Nima Ahmadi, CEO of The Wound Company, highlights the need for qualified and certified wound care experts to work with patients on a continuous basis. This kind of relationship allows the care provider to proactively manage the wound to ensure efficient healing as quickly as possible. Personalized plans are created using AI and data analysis, considering the patient's risk factors and specific details about the wound and their general health condition.

Nima explains, "We think about being in a continuous relationship with everybody who has a wound, ensuring its healing. Then, we continue to be proactive as we manage patients who are at risk of new wounds or repeat wounds so that we're doing everything we can preventatively to prevent that from happening. This is completely different than how we've approached wound care for the last few decades."

"We have certified experts, and our vision is that in ten years, every single American with a wound will have a certified wound care expert from The Wound Company assigned to their care. The expert is quarterbacking their wound care and ensuring they will heal as quickly and cost-effectively as possible. As part of that vision of assigning that coordination, we're also doing virtual and in-person, in some cases, wound care so that it's a one-stop shop experience for the patient to help them heal effectively and efficiently. And we have a tremendous amount of technology and other assets to help our clinicians do that multichannel wound care."

#WoundCare #OstomyCare #Healthcare #Telehealth #NursingShortage

thewound. co

Download the transcript here

Dr. Monique Nugent is a practicing hospitalist and an associate director for the Division of Hospital Medicine at South Shore Hospital in Weymouth, Massachusetts. She's also the author of Prescription for Admission: A Doctor's Guide for Navigating the Hospital, Advocating for Yourself, and Having a Better Hospitalization. Post-COVID, hospitals are dealing with workflow and getting patients in and out of the hospital as soon as possible. One big obstacle is the lack of places patients can go for rehabilitation and skilled nursing care, which is leading to more consideration of the hospital-at-home model. While this is a patient-facing book, there are insights about what healthcare providers need to understand about the patient hospital experience.

Monique explains, "Hospital-at-home is not a new concept. It's somewhat of a new concept here in the United States, but hospital-at-home has been successful around the world, and I think there's a lot of really good benefits."

"Number one, it cuts down on costs, and that's always a big issue in this country. A day in the hospital comes with costs, not just for the care, there's the cost of the building that goes into your hospitalization. There's the cost of the electricity for that building that is built into your hospitalization. So, it does drive down costs just by moving the care to a different facility, which is your home."

"I also think hospital-at-home is a big boon for the comfort of patients. Particularly our elderly patients. When they come into the hospital, often you'll see that people who struggle a little bit with their memory, who have a touch of dementia, or who have significant dementia can get very confused in the hospital. A, they're sick, B, these are new people, C, their routine is thrown off, and so that can worsen confusion and delirium."

#HospitalManagement #HospitalatHome #HospitalMedicine #Hospitalization #HospitalBasedPhysician

drmoniquenugent.com

Listen to the podcast here

Dr. Monique Nugent is a practicing hospitalist and an associate director for the Division of Hospital Medicine at South Shore Hospital in Weymouth, Massachusetts. She's also the author of Prescription for Admission: A Doctor's Guide for Navigating the Hospital, Advocating for Yourself, and Having a Better Hospitalization. Post-COVID, hospitals are dealing with workflow and getting patients in and out of the hospital as soon as possible. One big obstacle is the lack of places patients can go for rehabilitation and skilled nursing care, which is leading to more consideration of the hospital-at-home model. While this is a patient-facing book, there are insights about what healthcare providers need to understand about the patient hospital experience.

Monique explains, "Hospital-at-home is not a new concept. It's somewhat of a new concept here in the United States, but hospital-at-home has been successful around the world, and I think there's a lot of really good benefits."

"Number one, it cuts down on costs, and that's always a big issue in this country. A day in the hospital comes with costs, not just for the care, there's the cost of the building that goes into your hospitalization. There's the cost of the electricity for that building that is built into your hospitalization. So, it does drive down costs just by moving the care to a different facility, which is your home."

"I also think hospital-at-home is a big boon for the comfort of patients. Particularly our elderly patients. When they come into the hospital, often you'll see that people who struggle a little bit with their memory, who have a touch of dementia, or who have significant dementia can get very confused in the hospital. A, they're sick, B, these are new people, C, their routine is thrown off, and so that can worsen confusion and delirium."

#HospitalManagement #HospitalatHome #HospitalMedicine #Hospitalization #HospitalBasedPhysician

drmoniquenugent.com

Download the transcript here

Ryan McQuaid, Co-Founder of PlushCare, has expanded their collaborative virtual care model to provide whole-person care, including mental health and weight management. Working with partners, PlushCare offers primary care and referrals to specialists, second opinions, and therapists in all 50 states. Their top priority is to provide personalized care in a seamless fashion to all patients, especially those in underserved and rural communities.

Ryan elaborates, "Everybody's familiar with virtual care now. And so, given it's become a much more mature market, just like anything, as the market matures, consumers' expectations increase. And so, rewind five years ago, people were okay with maybe not the greatest experience when it came to a virtual visit, but now the bar has been raised substantially. And so, just making sure that patients get a wow experience has been one of our focuses."

"I think another area is being the one-stop shop. I talked about us joining forces with Accolade and 2nd MD to be the one place that people go for their health benefits, connecting with their primary care doctor, their therapist, even a weight management expert. And so, that's an area that we're leaning into substantially to be that one-stop shop. We believe that when you look at other markets and other ecosystems, whether it's Apple's ecosystem or Google's ecosystem, that's a trend you see in other industries in verticals."

@PlushCare #PlushCare #VirtualCare #Telehealth #PreventativeCare #MentalHealth #WeightManagement

PlushCare.com

Listen to the podcast here

Ryan McQuaid, Co-Founder of PlushCare, has expanded their collaborative virtual care model to provide whole-person care, including mental health and weight management. Working with partners, PlushCare offers primary care and referrals to specialists, second opinions, and therapists in all 50 states. Their top priority is to provide personalized care in a seamless fashion to all patients, especially those in underserved and rural communities.

Ryan elaborates, "Everybody's familiar with virtual care now. And so, given it's become a much more mature market, just like anything, as the market matures, consumers' expectations increase. And so, rewind five years ago, people were okay with maybe not the greatest experience when it came to a virtual visit, but now the bar has been raised substantially. And so, just making sure that patients get a wow experience has been one of our focuses."

"I think another area is being the one-stop shop. I talked about us joining forces with Accolade and 2nd MD to be the one place that people go for their health benefits, connecting with their primary care doctor, their therapist, even a weight management expert. And so, that's an area that we're leaning into substantially to be that one-stop shop. We believe that when you look at other markets and other ecosystems, whether it's Apple's ecosystem or Google's ecosystem, that's a trend you see in other industries in verticals."

@PlushCare #PlushCare #VirtualCare #Telehealth #PreventativeCare #MentalHealth #WeightManagement

PlushCare.com

Download the transcript here

Eli Ben-Joseph, Co-Founder and CEO of Regard, works with health systems to integrate AI into their medical record systems to help doctors by highlighting issues, aiding in the diagnosis, and writing medical notes after a patient visit. With increasing doctor burnout, an emphasis on more efficient workflow supported by technology is a path to giving providers more time with patients and less time on administrative issues and on their computers.

Eli explains, "We say that it's essentially an AI co-pilot for doctors. The way that works is we have a deep integration with leading medical records, both Epic and Cerner. And when a health system partners with us they will link our software to their system. When a doctor opens up Regard, the moment they click the Regard button, our technology goes into the medical record and fetches the entire medical record data for that patient. All the labs, all the history, all the vitals."

"What we recognized when we started this company is that doctors are spending way more time today than ever before having to make sure they document in a way that they can bill for it, that it doesn't get denied by insurance. They spend a lot of time dealing with prior authorizations or requirements that they have in terms of how they write their notes, and that's where that toil exists in healthcare. So we saw an opportunity to help automate a lot of those tasks, and that's where we step in."

"So, a quick story: one of my favorite stories is one of our physicians, long time user, was working on a patient who had a stroke and she opened up Regard. And our technology went through years of data in a matter of seconds and found a note from an outpatient doctor that said that this patient has an atrial fibrillation, which is a fluttering of the heart, which it's very important to know that if you're dealing with a stroke. Because of our technology, she was able to see something that she would not have seen otherwise, that this patient had an AFib. She would've totally missed it because it was years back in piles of data. And because of that, she was able to adjust the care that she gave this patient. And that had a really positive impact on that patient's care as well."

#RegardApp #ClinicianBurnout #AI #Workflow #Doctors #Physicians #Hospitals #NoteBloat

withregard.com

Listen to the podcast here

Eli Ben-Joseph, Co-Founder and CEO of Regard, works with health systems to integrate AI into their medical record systems to help doctors by highlighting issues, aiding in the diagnosis, and writing medical notes after a patient visit. With increasing doctor burnout, an emphasis on more efficient workflow supported by technology is a path to giving providers more time with patients and less time on administrative issues and on their computers.

Eli explains, "We say that it's essentially an AI co-pilot for doctors. The way that works is we have a deep integration with leading medical records, both Epic and Cerner. And when a health system partners with us they will link our software to their system. When a doctor opens up Regard, the moment they click the Regard button, our technology goes into the medical record and fetches the entire medical record data for that patient. All the labs, all the history, all the vitals."

"What we recognized when we started this company is that doctors are spending way more time today than ever before having to make sure they document in a way that they can bill for it, that it doesn't get denied by insurance. They spend a lot of time dealing with prior authorizations or requirements that they have in terms of how they write their notes, and that's where that toil exists in healthcare. So we saw an opportunity to help automate a lot of those tasks, and that's where we step in."

"So, a quick story: one of my favorite stories is one of our physicians, long time user, was working on a patient who had a stroke and she opened up Regard. And our technology went through years of data in a matter of seconds and found a note from an outpatient doctor that said that this patient has an atrial fibrillation, which is a fluttering of the heart, which it's very important to know that if you're dealing with a stroke. Because of our technology, she was able to see something that she would not have seen otherwise, that this patient had an AFib. She would've totally missed it because it was years back in piles of data. And because of that, she was able to adjust the care that she gave this patient. And that had a really positive impact on that patient's care as well."

#RegardApp #ClinicianBurnout #AI #Workflow #Doctors #Physicians #Hospitals #NoteBloat

withregard.com

Download the transcript here

Mark McDonough, the CEO of ChromaCode, is leveraging high-definition PCR testing to overcome the limitations of conventional PCR to identify biomarkers of infectious diseases and cancer. While gene sequencing can provide valuable information, it requires more tissue, is expensive, and requires at least a week for analysis. Using HDPCR, ChromaCode has developed a lung cancer assay that looks at nine genes and 15 biomarkers, requiring less tissue, performed at a lower cost, and provides results quickly. This approach, built on a cloud-supported multiplexing platform, provides flexibility to explore other areas in oncology and transplants, looking at multiple targets per sample.

Mark explains, "With PCR today, assays look at particular biomarkers on a gene-by-gene basis. So those can be effective in lung cancer, for example, if you know you're just looking for EGFR as a biomarker or if you're looking at KRAS or ALK, a different mutation. But the problem is it's not very comprehensive, and you need a lot of tissue. So, PCR falls short because it's limited in scalability and requires a lot of tissue."

"Why this is important for the patient in terms of patient empowerment and lung cancer is when a patient gets their result back from ChromaCode and their provider using ChromaCode technology, they also are more than likely having an immunochemistry test called PD-L1 run. They're trying to determine if there is a targeted therapy, or is it best to put a patient on immunotherapy, or is there a combination of immunotherapy and chemo?"

"Having all that answer back in one to two days, as opposed to knowing what you'll get back from immunochemistry in a day and then waiting two weeks for sequencing, can be very problematic. So, we feel like we're meeting that open opportunity where sequencing is too slow and too expensive, requiring too much tissue, and PCR just isn't comprehensive enough and is very much trial and error on a one-by-one basis with our technology."

#ChromaCode #HDPCR #Diagnostics #ChromaCodeCloud #Genomics #LungCancer #GeneSequencing

chromacode.com

Listen to the podcast here

Mark McDonough, the CEO of ChromaCode, is leveraging high-definition PCR testing to overcome the limitations of conventional PCR to identify biomarkers of infectious diseases and cancer. While gene sequencing can provide valuable information, it requires more tissue, is expensive, and requires at least a week for analysis. Using HDPCR, ChromaCode has developed a lung cancer assay that looks at nine genes and 15 biomarkers, requiring less tissue, performed at a lower cost, and provides results quickly. This approach, built on a cloud-supported multiplexing platform, provides flexibility to explore other areas in oncology and transplants, looking at multiple targets per sample.

Mark explains, "With PCR today, assays look at particular biomarkers on a gene-by-gene basis. So those can be effective in lung cancer, for example, if you know you're just looking for EGFR as a biomarker or if you're looking at KRAS or ALK, a different mutation. But the problem is it's not very comprehensive, and you need a lot of tissue. So, PCR falls short because it's limited in scalability and requires a lot of tissue."

"Why this is important for the patient in terms of patient empowerment and lung cancer is when a patient gets their result back from ChromaCode and their provider using ChromaCode technology, they also are more than likely having an immunochemistry test called PD-L1 run. They're trying to determine if there is a targeted therapy, or is it best to put a patient on immunotherapy, or is there a combination of immunotherapy and chemo?"

"Having all that answer back in one to two days, as opposed to knowing what you'll get back from immunochemistry in a day and then waiting two weeks for sequencing, can be very problematic. So, we feel like we're meeting that open opportunity where sequencing is too slow and too expensive, requiring too much tissue, and PCR just isn't comprehensive enough and is very much trial and error on a one-by-one basis with our technology."

#ChromaCode #HDPCR #Diagnostics #ChromaCodeCloud #Genomics #LungCancer #GeneSequencing

chromacode.com

Download the transcript here